Mentice

Hospital Training Demand Will Drive Long-Term Upside From Advanced Simulation Platforms

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

18 Dec 25

Views

n/a

AnalystConsensusTarget's Fair Value

n/a

-49.4%

-8.4%

-49.4%

-8.4%

You can edit this narrative until Dec 19 12:11 AM. Then, changes will post as Updates.

Author's Valuation

SEK 16.2522.5% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

SEK 16.25

22.5% undervalued

Future estimation in

Growth p.a.

Decrease

Increase

Current revenue growth rate

10.27%

Healthtech revenue growth rate

13.15%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

6.31%

Calculation

SEK 17.63m

Earnings '28

41.47x

PE Ratio '28

SEK 730.93m

Market Cap '28

SEK 730.93m

Market Cap '28

37.44m

No. shares '28

SEK 19.53

Share Price '28

SEK 19.53 Share Price '28

Discounted to 2025 @ 6.31% p.a.

SEK 16.25

Fair Value '25